PhaseBio

+$0.0129 (+1.69%) As of 4:50 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PhaseBio and other ETFs, options, and stocks.

About PHAS

PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapies for cardiovascular diseases. The firm's pipeline includes: bentracimab (PB2452), a novel reversal agent for the antiplatelet therapy ticagrelor, pemziviptadil (PB1046), a once-weekly vasoactive intestinal peptide receptor agonist for the treatment of pulmonary arterial hypertension, and PB6440, an oral agent for the treatment of resistant hypertension.

CEO
Jonathan P. Mow
Employees
60
Headquarters
Malvern, Pennsylvania
Founded
2002

PHAS Key Statistics

Market cap
38.11M
Price-Earnings ratio
—
Dividend yield
—
Average volume
618.18K
High today
$0.80
Low today
$0.7499
Open price
$0.77
Volume
244.32K
52 Week high
$4.24
52 Week low
$0.7499

PHAS Earnings

-$1.03
-$0.69
-$0.34
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.66 per share
Actual
-$0.23 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure